June 16, 2024

Revolutionizing Diabetes Management: The FDA Clears ‘Bionic Pancreas’ for Commercial Use

2 min read
Type 1 diabetes is no match for this gymnast

The FDA has recently approved a revolutionary device for diabetics called the “bionic pancreas,” which can take the burden of constantly monitoring carbohydrate intake off users. This innovative device allows users to simply input the size of their next meal, and an AI algorithm determines the precise amount of insulin needed to maintain stable blood sugar levels. The iLet device, cleared for commercial use, has been life-changing for 15-year-old Mia Campos, a skilled gymnast from San Antonio who has been living with type 1 diabetes for five years.

Mia was diagnosed with diabetes during a gymnastics competition when she began experiencing symptoms such as excessive thirst and frequent urination. She was fitted with a traditional insulin pump that required constant programming and often experienced glitches. However, her pediatric endocrinologist recommended the “bionic pancreas,” which has now been approved by the FDA for commercial use. Clipped to her jeans, the device uses AI software to tailor insulin delivery to her glucose levels.

The iLet device is suitable for individuals aged six and up and requires only one input regarding the size of the user’s next meal. The device then learns the user’s biorhythms and delivers insulin accordingly, keeping blood sugar levels stable. Mia is thrilled with the benefits of this technology, allowing her to focus on her homework and gymnastics training rather than constantly worrying about her carb intake and insulin levels.

The “bionic pancreas” uses a plastic infusion set attached to the body to communicate with sensors and deliver insulin as needed. Dr. Lynch, Mia’s pediatric endocrinologist, emphasizes that diet and exercise are still critical components of managing blood sugar levels. Mia believes that this new technology will greatly benefit individuals, particularly children, who have busy lives and struggle to manually track their carb intake.

In conclusion, the approval of the “bionic pancreas” by the FDA marks a significant step forward in diabetes management. This innovative device offers diabetics a simple solution to manage their blood sugar levels without having to worry about constant monitoring of their carb intake or dealing with glitches in traditional insulin pumps. With its ease of use and effectiveness, this technology is sure to be a game-changer in diabetes care for many individuals in the future.

Leave a Reply

Copyright © All rights reserved. | Newsphere by AF themes.